On December 6, 2024, Synaptogenix, Inc. held its Annual Meeting where stockholders voted on four proposals, including the election of directors and amendments to the equity incentive plan, with 54.03% of shares represented. Key votes included the election of Joshua Silverman and William S. Singer as directors, authorization to issue stock, and an increase in shares for the equity plan from 175,000 to 675,000.